RIBU

Development Stage Prototype
Target Date 30.03.2025
Target Sectors Health Technologies

Ürün Tanımı

The infection analyzer is a biosensor that detects the infection caused by pathogens with biological elements (blood, urine, etc.) taken from the human body.

Aksense has developed the RIBU, a rapid, portable diagnostic biosensor to provide healthcare providers with high quality and safe care.

RIBU consists of a pocket portable electronic reader with unique sensors that can identify multiple pathogens and communicates and shares test results with smart devices. It identifies the infection in any part of the body from a drop of blood sample placed on the sensors with its unique detection system.


Marketsize

The point-of-care (PoC) diagnostics market is anticipated to reach USD 75.5 billion by 2027, with a projected CAGR of 10.7%.